
New England Biolabs is an American life sciences company which produces and supplies recombinant and native enzyme reagents for life science research. It also provides products and services supporting genome editing, synthetic biology and next-generation sequencing. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for New England Biolabs (China), China, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
74%
Total
Publications
141
Total Open
Publications
104
Total
Citations
3.9K
Open Access
Percentage
74%
Total
Publications
141
Total Open
Publications
104
Total
Citations
3.9K
Breakdown
Publisher Open
11%
Both
38%
Other Platform Open
19%
Closed
32%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 70%
39
Hybrid 21%
12
No Guarantees 9%
5
Other Platform Open
Domain 60%
39
Preprint 29%
19
Other Internet 17%
11
Institution 9%
6
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 39 |
bioRxiv | Preprint | 12 |
DOI | Other Internet | 11 |
Research Square | Preprint | 7 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 5 |
University of Nottingham | Institution | 1 |
Leibniz University Hannover | Institution | 1 |
Europe PMC | Domain | 1 |
Boston University | Institution | 1 |